Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: Diseases of oxidative stress and aging?

Archives of Neurology

Volumn 55, Issue 7, 1998, Pages 915-920

  Askanas, Valerie ^a   Engel, W King ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CONGO RED; CRYSTAL VIOLET; CYTOCHROME C OXIDASE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PRION PROTEIN; PROTEIN; SUPEROXIDE DISMUTASE; TAU PROTEIN; THIOFLAVINE; TYROSINE; UBIQUITIN;

AGING; ELECTRON MICROSCOPY; HUMAN; INCLUSION BODY MYOSITIS; MICROSCOPY; MUSCLE BIOPSY; NEUROMUSCULAR SYNAPSE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

AGING; BIOPSY; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCLUSION BODIES; MUSCULAR DISEASES; MYOSITIS, INCLUSION BODY; OXIDATIVE STRESS; PERIODICITY;

EID: 0031864547     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.7.915     Document Type: Review

References (24)

1. Yunis EJ, Samaha FJ. Inclusion-body myositis. Lab Invest. 1971;25:240-248.
2. Askanas V, Engel WK. New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies. Curr Opin Rheumatol. 1995;7:486-496.
3. Askanas V, Engel WK. Newest approaches to diagnosis and pathogenesis of sporadic inclusion-body myositis and hereditary inclusion-body myopathies, including molecular-pathologic similarities to Alzheimer disease. In: Askanas V, Serratrice G, Engel WK, eds. Inclusion-Body Myositis and Myopathies. Cambridge, England: Cambridge University Press; 1998:3-78.
4. Askanas V,Engel WK. New advances in inclusion-body myositis. Curr Opin Rheumatol. 1993;5:732-741.
5. Murakami N, Ihara Y, Nonaka I. Muscle fiber degeneration in distal myopathy with rimmed vacuole formation. Acta Neuropathol (Berl). 1995;89:29-34.
6. Ikeuchi T, Asaka T, Saito M, et al. Gene locus for autosomal recessive distal myopathy with rimmed vacuoles maps to chromosome 9. Ann Neurol. 1997;41: 432-437.
7. Mitrani-Rosenbaum S, Argov Z, Blumenfeld A, Seidman CD, Seidman JG. Hereditary inclusion-body myopathy maps to chromosome 9p1-q1. Hum Mol Genet. 1996;5:159-163.
8. Askanas V. New developments in hereditary inclusion-body myopathies. Ann Neurol. 1997;41:421-422.
9. Argov Z, Tiram E, Eisenberg I, et al. Various types of hereditary inclusion-body myopathies map to chromosome 9p1-q1. Ann Neurol. 1997;41:548-551.
10. Middleton LT, Christodoulou K, Askanas V, et al. Molecular genetics of autosomal-recessive hereditary inclusion-body myopathy (AR-IBM) [abstract]. Ann Neurol. 1997;42:414.
11. Mendell JR, Sahenk Z, Gales T, Paul L. Amyloid filaments in inclusion-body myositis. Arch Neurol. 1991;48:1229-1234.
12. Oldfors A, Moslemi A-R, Fyhr I-M, Holme E, Larsson N-G, Lindberg C. Mitochondrial DNA deletions in muscle fibers in inclusion-body myositis. J Neuropathol Exp Neurol. 1995;54:581-587.
13. Santorelli FM, Sciacco M, Tanji K, et al. Multiple mitochondrial DNA deletions in sporadic inclusion-body myositis: a study of 56 patients. Ann Neural. 1996;39: 789-795.
14. Desnuelle C, Paquis V, Paul R, et al. mtDNA analysis in muscle of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy. In: Askanas V, Serratrice G, Engel WK, eds. Inclusion-Body Myositis and Myopathies. Cambridge, England: Cambridge University Press; 1998;318-328.
15. Eeckman JS, Koppenol WH. Nitric oxide, Superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 1996;271:C1424-C1437.
16. Broccolini A, Engel WK, Alvarez RB, Thomas CE, Yang C-C, Askanas V. Possible pathogenic role of malondialdehyde, a toxic product of lipid peroxidation, in inclusion-body myositis [abstract]. Neurology. 1998;50:367-368.
17. Butterfield DA. β-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem Res Toxicol. 1997;10:495-506.
18. Dalakas MC, Sivakumar K. The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion-body myositis. Curr Opin Neurol. 1996;9:235-239.
19. Hino S, Doi H. Mechanisms of HTLV-1 transmission. In: Roman GC, Vernant J-C, Osame M, Hurst MJ, eds. HTLV-1 and the Nervous System. New York, NY: Alan R Liss Inc; 1989;495-501.
20. Engel WK, Haginoya K, Alvarez RB, Sabetian K, Bajoghli M, Askanas V. Sporadic inclusion-body myositis (s-IBM) in an HTLV-I-positive Iranian Muslim [abstract]. Neurology. 1997;48:124.
21. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med. 1997;23:134-147.
22. Lippa CF, Saunders AM, Smith TW, et al. Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway. Neurology. 1996; 46:406-412.
23. Prusiner SB, Hsiao KK. Human prion diseases. Ann Neurol. 1994;35:385-395.
24. Askanas V, Engel WK, Alvarez RB. Fourteen newly recognized proteins at the human neuromuscular junctions - and their non-junctional accumulation in inclusion-body myositis. In: Richman DP, ed. Myasthenia Gravis and Related Diseases: Disorders of the Neuromuscular Junction. Vol 841. New York, NY; Annals of New York Academy of Sciences; 1998;841:28-56.